Comparing High LET <sup>227</sup>Th- and Low LET <sup>177</sup>Lu-trastuzumab in Mice with HER-2 Positive SKBR-3 Xenografts

Nasir Abbas, Jostein Dahle(Oslo University Hospital), Øyvind S. Bruland(University of Oslo), Helèn Heyerdahl(Nordic Nanovector (Norway)), Ellen Mengshoel Brevik
Current Radiopharmaceuticals
April 23, 2013
Cited by 15


Related Papers